- Indiana University Policy on Dual Use Research of Concern and Pathogens with Enhanced Pandemic Potential
- Unites States Government Policy for Oversight of Dual Use Research of Concern and Pathogens with Enhanced Pandemic Potential
- Principal Investigator Self-Assessment Form
- Templates:
- Risk Assessment Template
- Mitigation Plan
DURC Agents
Category 1 Agents
- Abrin
- Bacillus cereus Biovar anthracis
- Botulinum neurotoxins
- Botulinum neurotoxin producing species of Clostridium
- Conotoxins (Short, paralytic alpha conotoxins containing the following amino acid sequence X1CCX2PACGX3X4X5X6CX7)
- Coxiella burnetii
- Crimean-Congo haemorrhagic fever virus
- Diacetoxyscirpenol
- Eastern Equine Encephalitis virus
- Ebolaviruses (including Bombali, Bundibugyo, Ebola, Reston, Sudan, and Tai Forest viruses)
- Francisella tularensis
- Lassa virus
- Lujo virus
- Marburg virus
- Monkeypox virus, clade I
- Reconstructed replication-competent forms of the 1918 pandemic influenza virus containing any portion of the coding regions of all eight gene segments (Reconstructed 1918 Influenza virus)
- Ricin
- Rickettsia prowazekii
- SARS-associated coronavirus (SARS-CoV)
- SARS-CoV/SARS-CoV-2 chimeric viruses resulting from any deliberate manipulation of SARS-CoV-2 to incorporate nucleic acids coding for SARS-CoV virulence factors
- Saxitoxin
- South American Hemorrhagic Fever viruses:
- Chapare
- Guanarito
- Junín
- Machupo
- Sabia
- Staphylococcal enterotoxins (subtypes A,B,C,D,E)
- T-2 toxin
- Tetrodotoxin
- Tick-borne encephalitis complex (flavi) viruses:
- Far-Eastern subtype
- Siberian subtype
- Kyasanur Forest disease virus
- Omsk hemorrhagic fever virus
- Variola major virus (Smallpox virus)
- Variola minor virus (Alastrim)
- Yersinia pestis
Overlap Select Agents and Toxins
- Bacillus anthracis
- Bacillus anthracis Pasteur strain
- Burkholderia mallei
- Burkholderia pseudomallei
- Hendra virus
- Nipah virus
- Rift Valley fever virus (except #1 MP-12 vaccine strain)
- Venezuelan equine encephalitis virus (except TC83 and V3526 strains)
- African swine fever virus
- Avian influenza virus
- Classical swine fever virus
- Foot-and-mouth disease virus
- Goat pox virus
- Lumpy skin disease virus
- Mycoplasma capricolum
- Mycoplasma mycoides
- Newcastle disease virus
- Peste des petits ruminants virus
- Rinderpest virus
- Sheep pox virus
- Swine vesicular disease virus
- Coniothyrium glycines (formerly Phoma glycinicola and Pyrenochaeta glycines)
- Ralstonia solanacearum
- Rathayibacter toxicus
- Sclerophthora rayssiae
- Synchytrium endobioticum
- Xanthomonas oryzae
https://osp.od.nih.gov/wp-content/uploads/NIH_Guidelines.pdf
Risk Group 4 (RG4) - Bacterial Agents
- None
Risk Group 4 (RG4) - Fungal Agents
- None
Risk Group 4 (RG4) - Parasitic Agents
- None
Risk Group 4 (RG4) - Viral Agents
- Arenaviruses
- Chapare virus
- Guanarito virus
- Junín virus (except the candid #1 vaccine strain listed in Appendix B-II-D Risk Group2 (RG2) – Viruses)
- Lassa virus
- Lujo virus
- Machupo virus
- Sabia
- Bunyaviruses (Nairovirus)
- Crimean-Congo hemorrhagic fever virus
- Filoviruses
- Ebolaviruses, including Bombali, Bundibugyo, Ebola, Reston, Sudan, and Tai Forest viruses
- Marburg viruses, including Marburg and Ravn viruses
- Flaviruses - Group B Arboviruses
- Tick-borne encephalitis virus complex including Absetterov, Alkhurma hemorrhagic fever, Central European encephalitis, Hanzalova, Hypr, Kumlinge, Kyasanur Forest disease, Nanjianyin, Omsk hemorrhagic fever, and Russian spring-summer encephalitis viruses
- Herpesviruses (alpha)
- Herpesvirus simiae (Herpes B or Monkey B virus)
- Paramyxoviruses
- Hendra virus
- Nipah virus
- Hemorrhagic fever viruses as yet undefined
Risk Group 3 (RG3) - Bacterial Agents Including Rickettsia*
- Bartonella
- Brucella including canis
- Burkholderia (Pseudomonas) mallei, B. pseudomallei
- Coxiella burnetii (except the Phase II, Nine Mile strain listed in Appendix B-II-A, Risk Group 2 (RG2) - Bacterial Agents Including Chlamydia)
- Francisella tularensis (except those strains listed in Appendix B-II-A, Risk Group 2 (RG2) – Bacterial Agents Including Chlamydia)
- Orientia tsutsugamushi (was tsutsugamushi)
- Pasteurella multocida type B -"buffalo" and other virulent strains
- Rickettsia akari, R. australis, R. canada, R. conorii, R. prowazekii, R. rickettsii, R. siberica, R. typhi ( mooseri)
- Yersinia pestis (except those strains listed in Appendix B-II-A, Risk Group 2 (RG2) - Bacterial Agents Including Chlamydia)
Risk Group 3 (RG3) - Fungal Agents*
- None
Risk Group 3 (RG3) - Parasitic Agents
- None
Risk Group 3 (RG3) - Viruses and Prions*
- Alphaviruses (Togaviruses) - Group A Arboviruses
- Chikungunya virus (except the vaccine strain 181/25 listed in Appendix B-II-D Risk Group2 (RG2) – Viruses)
- Semliki Forest virus
- Venezuelan equine encephalomyelitis virus (except the vaccine strains TC-83 and V3526, see Appendix B-II-D (RG2) – Viruses)
- Other viruses as listed in the reference source (see Section V-C, Footnotes and References of Sections I through IV)
- Arenaviruses
- Flexal
- Lymphocytic choriomeningitis virus (LCM) (neurotropic strains)
- Bunyaviruses
- Hantaviruses, including Hantaan virus
- Rift Valley fever virus (except #1 MP-12)
- Coronaviruses
- SARS-associated coronavirus (SARS-CoV)
- Middle East respiratory syndrome coronavirus (MERS-CoV)
- Flaviviruses - Group B Arboviruses
- Japanese encephalitis virus (except those strains listed in Appendix B-II-D Risk Group2 (RG2) - Viruses)
- Yellow fever virus (except 17-D)
- Other viruses as listed in the reference source (see Section V-C, Footnotes and References of Sections I through IV)
- Orthomyxoviruses
- Influenza viruses 1918-1919 H1N1 (1918 H1N1), human H2N2 (1957-1968), and highly pathogenic avian influenza H5N1 strains within the Goose/Guangdong/96-like H5 lineage (HPAI H5N1).
- Poxviruses
- Monkeypox virus (Clade I & Clade II containing nucleic acids coding for clade I MPVX virus virulence factors)
- Prions
- Transmissible spongiform encephalopathies (TSE) agents (Creutzfeldt-Jacob disease and kuru agents)(see Section V-C, Footnotes and References of Sections I through IV, for containment instruction)
- Human immunodeficiency virus (HIV) types 1 and 2
- Human T cell lymphotropic virus (HTLV) types 1 and 2
- Simian immunodeficiency virus (SIV)
- Mycobacterium tuberculosis, Mycobacterium bovis
- Clade II of MPVX viruses unless containing nucleic acids coding for clade I MPVX virus virulence factors
- Vesicular stomatitis virus
- Coccidioides immitis and Coccidioides posadasii (sporulating cultures; contaminated soil)
- Sporulating cultures of Histoplasma capsulatum, capsulatum var. Duboisii
- Sporulating cultures of Blastomyces (e.g., B. dermatitidis, B. gilchristii)
Resources and Support
Contact the Institutional Biosafety Committee
The Indiana University Research Safety Office provides support to all IU campuses. Contact the Research Safety Office at IBC@iu.edu or 812-855-0656. You may also schedule a virtual meeting with a member of the Research Safety Office.